Faruqi and Faruqui, LLP Logo
Share this page

Novan, Inc. (NOVN)



Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Novan, Inc.  To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Novan, Inc. (“Novan” or the “Company”) (NASDAQ:NOVN)

The investigation focuses on whether the Company and its executives violated federal securities laws.

Specifically, during pre-market trading on January 27, 2017, the Company announced that Novan’s two phase 3 pivotal clinical trials for its topical acne treatment had yielded different results.  The Company revealed one trial showed statistical significance for all three co-primary endpoints and the other trial showed significance on only one.  On this news, Novan’s share price was negatively affected, causing investors harm.

Take Action

If you invested in Novan stock or options and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Novan’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Novan, Inc. (NOVN)

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330


Case Details


  • 01/27/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.